Login
Aphria NASDAQ: APHA
Aphria Inc. produces and sells medical cannabis in Canada and internationally
| Name | Aphria |
| Ticker | APHA |
| Exchange | NASDAQ |
| Sector | Health Care |
| Industry | Cannabis Producer |
|
Price
52W Low/High |
15.38
4.22 / 26.30 |
| Momentum | Sharp Down |
| Market cap | 4.9 B |
| 1Y Total Return |
200.98 %
Strong |
| 1Y Volatility |
95.25 %
High Risk |
Relative Strength Index : Attempt to identify overbought (above 80) and oversold (below 20) conditions
Aphria Inc. produces and sells medical cannabis in Canada and internationally
Details
| Ticker | APHA |
| Name | Aphria |
| ISIN | CA03765K1049 |
| CUSIP | 03765K104 |
| Exchange | NASDAQ |
| Sector | Health Care |
| Industry | Cannabis Producer |
| Country | Canada |
| Currency | U.S. Dollar |
Share as of 04/30/2021
| Close Price | 15.38 |
| 52W Low/High | 4.22 / 26.30 |
| Market cap | 4.9 B |
| 1Y Total Return |
200.98 %
Strong |
| 1Y Volatility |
95.25 %
High Risk |
| Beta | 2.09 |
| PE (trailing) | - |
| 12M Dividends | - |
| Last Dividend Date | - |
| Dividend Yield | - |
Fin. Strength
| Net Profit Margin | -95.7 % |
| Cash from Op. / Cur. Liabilities | -0.34 |
| Diluted Earnings / Share | -1.56 |
| ROE | - |
| ROIC | -38.1 % |
| Price / Revenue | 10.0 |
| Price / Book | 4.1 |
| Price / CF | -82.7 |
| Current Ratio | 3.4 |
| Cur.Liabilities / Tot.Liabilities | 0.2 |
| Financial Leverage | 0.62 |
| in Mils USD |
rolling-year up to March
|
||||
|---|---|---|---|---|---|
| Income Statement | 2021 | 2020 | 2019 | 2018 | |
| Revenue |
486
|
388
|
92
|
-
|
|
| Gross Profit |
154
|
137
|
42
|
-
|
|
| R&D |
1
|
2
|
1
|
-
|
|
| EBITDA |
-395
|
75
|
-23
|
-
|
|
| Operating Income |
-127
|
-16
|
-95
|
-
|
|
| Net Income exc. Extra |
-
|
22
|
-
|
-
|
|
| per Share | |||||
| Diluted avg Shares |
317
|
258
|
250
|
-
|
|
| EPS exc. Extra |
-1.56
|
0.09
|
-0.12
|
-
|
|
| Dividend |
-
|
-
|
-
|
-
|
|
| Div. Yield (an.) |
-
|
-
|
-
|
-
|
|
| Balance Sheet | 2021 | 2020 | 2019 | 2018 | |
| Total Assets |
2,226
|
1,942
|
1,561
|
-
|
|
| Cash, Eq & Invt ShortTerm |
217
|
412
|
111
|
-
|
|
| Total Current Assets |
580
|
690
|
235
|
-
|
|
| Total Non-Current Assets |
1,647
|
1,252
|
1,326
|
-
|
|
| Intangibles |
1,124
|
785
|
808
|
-
|
|
| Total Liabilities |
983
|
551
|
259
|
-
|
|
| Total Current Liabilities |
172
|
133
|
135
|
-
|
|
| Long Term Debt |
811
|
418
|
124
|
-
|
|
| Shareholder equity |
1,197
|
1,371
|
1,280
|
-
|
|
| Cash Flow | 2021 | 2020 | 2019 | 2018 | |
| Cash from Operations |
-59
|
-105
|
-33
|
-
|
|
| Depreciation |
55
|
32
|
14
|
-
|
|
| Cash from Investing |
-300
|
-57
|
-185
|
-
|
|
| Capex |
49
|
109
|
171
|
-
|
|
| Cash from Financing |
178
|
468
|
208
|
-
|
|
| Stock Issued |
101
|
79
|
194
|
-
|
|
| Debt (LT) Issued |
89
|
388
|
15
|
-
|
|
| Free Cash Flow |
-683
|
-217
|
-
|
-
|
|
| Ratios | 2021 | 2020 | 2019 | 2018 | |
| Net Profit Margin |
-
|
5.8 %
|
-
|
-
|
|
| NCFO / Op.Income |
-
|
-
|
-
|
-
|
|
| Current Ratio |
3.4
|
5.2
|
1.7
|
-
|
|
| Financial Leverage D/E |
0.62
|
0.26
|
0.05
|
-
|
|
| Return on Capital Avg |
-38.1 %
|
3.6 %
|
-5.3 %
|
-
|
|
| Return on Shareholder Equity |
-
|
1.7 %
|
-
|
-
|
|
Fundamentals
No documents are available for the moment, please check back soon, or save the asset to be notified when documents are available